Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05975359 · ClinicalTrials.gov registry record · NA

Assessment of the Interi Manifold in Implant-Based Breast Reconstruction

A NA study of Mastectomy and Implant Based Breast Reconstruction, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05975359: Recruiting NA study of Mastectomy and Implant Based Breast Reconstruction, sponsored by Stanford University.

NCT05975359 is a NA study of Mastectomy and Implant Based Breast Reconstruction that is actively recruiting participants, run by Stanford University. The registered enrollment target is 20 participants, below the 130-participant average among 8 other Mastectomy trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05975359, a NA study of Mastectomy and Implant Based Breast Reconstruction, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Patients with breast cancer that elect to undergo implant-based breast reconstruction (IBBR) often require the placement of a surgical drain. Surgical drains are used to manage dead space and prevent seroma formation or accumulation of fluid within the surgical field postoperatively. The most frequently used drain is a Jackson-Pratt (JP) drain, which is limited by poor surgical site coverage and low capacity, leading to inconsistent suction and prolonged time that a drain is left in place. The Interi Drain system is a novel, multi-branched manifold with a proprietary suction system that provides consistent suction and addresses many of the shortcoming of JP drains. The purpose of this study is to compare the Interi system to standard JP drains across outcomes including number of surgical drain sites, complication rates, time to drain removal, time to initiate tissue expansion, total fluid volume drained, and patient satisfaction.

Primary Outcome

Incidence of adverse events or complications (e.g. seroma, hematoma, infection, dehiscence, etc.) will be recorded for both drain systems.

Interventions

  • DEVICE Interi Manifold Drain System
  • DEVICE Jackson Pratt Drain System

Study Locations (1)

California

  • Stanford Hospital and Clinics - Palo Alto

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2023-10-05
Est. Completion 2026-03
Phase NA
Stanford University

1,744 total trials

What NCT05975359 shows while recruiting

NCT05975359 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 130-participant average among 8 other Mastectomy trials with a reported enrollment target (85% lower).

The record links to 2 conditions, with Mastectomy appearing as the primary indexed condition, and to 2 interventions - of which Interi Manifold Drain System is the first listed.

NCT05975359 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05975359 about?

NCT05975359 is a clinical study titled "Assessment of the Interi Manifold in Implant-Based Breast Reconstruction". Patients with breast cancer that elect to undergo implant-based breast reconstruction (IBBR) often require the placement of a surgical drain. Surgical drains are used to manage dead space and prevent seroma formation or accumulation of fluid within the surgical field postoperatively. The most freque...

What is the current status of trial NCT05975359?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-10-05. Estimated completion is 2026-03.

What conditions does trial NCT05975359 study?

This clinical trial studies the following conditions: Mastectomy, Implant Based Breast Reconstruction.

What interventions are being tested in trial NCT05975359?

The interventions under investigation include: Interi Manifold Drain System (DEVICE), Jackson Pratt Drain System (DEVICE).

Who is sponsoring clinical trial NCT05975359?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05975359 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mastectomy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05975359's enrollment target sits among peer trials

20 7th of 8 higher than 2 of 8 other Mastectomy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mastectomy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05975359, the US trial registry maintained by the National Library of Medicine. NCT05975359 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.